North America Medical Second Opinion Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The North America medical second opinion market is projected to grow significantly, reaching approximately USD 7.30 billion by 2031, up from USD 2.48 billion in 2023, with a compound annual growth rate (CAGR) of 14.4% during this period.

Executive Summary and Market Analysis

The medical second opinion market in North America is divided into three main regions: the United States, Canada, and Mexico. The growth of this market is driven by the increasing acceptance of medical second opinion services and the ongoing digital transformation in healthcare consulting. Additionally, advancements in healthcare systems and a heightened focus on improving treatment outcomes are expected to further propel market growth.

Market Segmentation Analysis

The North America medical second opinion market can be analyzed based on two key segments: medical conditions and service providers.

1. By Condition: The market is categorized into various medical conditions, including cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. Notably, the cancer segment accounted for the largest market share in 2023.

2. By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. In 2023, hospitals represented the largest share of the market.

Market Outlook

Globally, patients are facing increasing financial pressures due to rising healthcare costs, which are exacerbated by a shortage of healthcare professionals and limited resources. This situation has created a demand for healthcare cost optimization. The need for second medical opinions is growing as patients seek to avoid unnecessary surgeries and complications. Medical second opinion services provide patients with comprehensive information to make informed decisions regarding their treatment options. These services often involve a thorough review of medical records and alternative treatment assessments, which can lead to reduced healthcare costs and improved patient outcomes.

Research indicates that approximately 31% of patients experience complications from surgical procedures, and around 4.2 million postoperative deaths occur annually, highlighting the importance of second opinions in mitigating risks associated with surgery.

Country Insights

The North American medical second opinion market is primarily driven by the United States, which held the largest market share in 2023. The rising incidence of cancer, which is the second leading cause of death in the U.S., presents significant opportunities for growth in this market. In 2022, over 1.9 million new cancer cases were diagnosed, leading to approximately 609,360 deaths. Projections suggest that around 2 million new cancer cases will be diagnosed in 2024, further increasing the demand for second opinions, especially given the prevalence of misdiagnoses.

Moreover, the U.S. faces a high rate of medical errors, with around 4,000 surgical errors reported annually and 7,000 to 9,000 deaths attributed to medication errors. Approximately 795,000 Americans suffer from misdiagnoses of serious conditions each year, underscoring the critical need for second opinions in the healthcare system.

In response to these challenges, organizations like UnitedHealthcare have partnered with companies such as 2nd.MD to offer no-cost expert medical opinion services to their members. This service connects patients with specialists who review their cases and provide second opinions. Other organizations, such as WorldCare International Inc., also offer comprehensive second opinion services for critical illnesses, covering a wide range of medical conditions.

Company Profiles

Key players in the North America medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors. These companies are employing various strategies, including market expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical second opinion market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in North America medical second opinion market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the medical second opinion market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.